Amneal Pharmaceuticals, Inc.
Ownership
Ownership Structure
Who owns Amneal Pharmaceuticals, Inc. (AMRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.7% of the shares are freely tradable; institutional investors hold 52.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.04 | 24,519,192 | +71.5 | 03/31/2026 |
| TPG GP A, LLC | 3.54 | 12,328,767 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.25 | 11,324,933 | +0.0 | 03/31/2026 |
| Rubric Capital Management LP | 3.17 | 11,037,589 | -10.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.18 | 7,585,034 | +0.0 | 03/31/2026 |
| State Street Corp | 1.95 | 6,794,702 | +65.3 | 03/31/2026 |
| Dimensional Fund Advisors, Inc. | 1.66 | 5,794,263 | +1.8 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 1.33 | 4,637,185 | -3.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3.02 | 10,503,994 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.60 | 5,586,542 | +0.5 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Patel Tushar Bhikhubhai | 10% Owner | 61,341,678 | 1,122,552,707 $ | Aug 10, 2026 | indirect |
| Patel Chintu | Co-CEO | 6,381,734 | 116,785,732 $ | Aug 10, 2026 | indirect |
| Patel Chirag K. | President & Co-CEO | 6,381,734 | 116,785,732 $ | Aug 10, 2026 | indirect |
| Patel Gautam | Director | 283,632 | 5,190,466 $ | Aug 10, 2026 | indirect |
| Shah Nikita | Executive Vice President | 253,390 | 4,637,037 $ | Aug 12, 2026 | direct |
| Kiely John | Director | 200,252 | 3,664,612 $ | Aug 13, 2026 | direct |
| Boyer Andrew S | Executive Vice President | 193,646 | 3,543,722 $ | Sep 1, 2026 | direct |
| Buchi J Kevin | Director | 189,021 | 3,459,084 $ | Aug 11, 2026 | both |
| Daly Jason B. | EVP, Chief Legal Officer | 35,171 | 643,629 $ | Aug 12, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Buchi J Kevin | Director | Other | 20,445 | 14.45 | 295,430 |
| Sep 1, 2026 | Boyer Andrew S | Executive Vice President | Other | 80,000 | 0.00 | – |
| Aug 21, 2026 | Boyer Andrew S | Executive Vice President | Other | 152,426 | 0.00 | – |
| Aug 13, 2026 | Kiely John | Director | Other | 10,000 | 0.00 | – |
| Aug 13, 2026 | Kiely John | Director | Sell | 50,000 | 17.64 | 882,000 |
| Aug 12, 2026 | Shah Nikita | Executive Vice President | Sell | 146,403 | 17.51 | 2,563,517 |
| Aug 12, 2026 | Daly Jason B. | EVP, Chief Legal Officer | Sell | 210,000 | 17.40 | 3,654,000 |
| Aug 11, 2026 | Daly Jason B. | EVP, Chief Legal Officer | Sell | 6,613 | 17.70 | 117,050 |
| Aug 11, 2026 | Buchi J Kevin | Director | Other | 168,573 | 17.18 | 2,896,084 |
| Aug 10, 2026 | Patel Chintu | Co-CEO | Other | 6,381,734 | – | – |
| Aug 10, 2026 | Patel Gautam | Director | Other | 283,632 | – | – |
| Aug 10, 2026 | Patel Chirag K. | President & Co-CEO | Other | 6,381,734 | – | – |
| Aug 10, 2026 | Patel Tushar Bhikhubhai | 10% Owner | Other | 12,763,469 | – | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.